Literature DB >> 20536554

Perforin: structure, function, and role in human immunopathology.

Ilia Voskoboinik1, Michelle A Dunstone, Katherine Baran, James C Whisstock, Joseph A Trapani.   

Abstract

The secretory granule-mediated cell death pathway is the key mechanism for elimination of virus-infected and transformed target cells by cytotoxic lymphocytes. The formation of the immunological synapse between an effector and a target cell leads to exocytic trafficking of the secretory granules and the release of their contents, which include pro-apoptotic serine proteases, granzymes, and pore-forming perforin into the synapse. There, perforin polymerizes and forms a transmembrane pore that allows the delivery of granzymes into the cytosol, where they initiate various apoptotic death pathways. Unlike relatively redundant individual granzymes, functional perforin is absolutely essential for cytotoxic lymphocyte function and immune regulation in the host. Nevertheless, perforin is still the least studied and understood cytotoxic molecule in the immune system. In this review, we discuss the current state of affairs in the perforin field: the protein's structure and function as well as its role in immune-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536554     DOI: 10.1111/j.0105-2896.2010.00896.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  66 in total

1.  Critical role for perforin and Fas-dependent killing of dendritic cells in the control of inflammation.

Authors:  Min Chen; Kumar Felix; Jin Wang
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

2.  Functionality of CD4+ and CD8+ T cells from tonsillar tissue.

Authors:  I Sada-Ovalle; A Talayero; L Chavéz-Galán; L Barrera; A Castorena-Maldonado; A Soda-Merhy; L Torre-Bouscoulet
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

3.  Cancer-derived matrix metalloproteinase-9 contributes to tumor tolerance.

Authors:  Bin-Quan Wang; Chun-Ming Zhang; Wei Gao; Xu-Feng Wang; Hai-Li Zhang; Ping-Chang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-11       Impact factor: 4.553

Review 4.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

5.  A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation.

Authors:  N Clemente; E Boggio; C L Gigliotti; E Orilieri; G Cappellano; E Toth; P A Valletti; C Santoro; I Quinti; C Pignata; L D Notarangelo; C Dianzani; I Dianzani; U Ramenghi; U Dianzani; A Chiocchetti
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

6.  Identification of Serpinb6b as a species-specific mouse granzyme A inhibitor suggests functional divergence between human and mouse granzyme A.

Authors:  Dion Kaiserman; Sarah E Stewart; Kim Plasman; Kris Gevaert; Petra Van Damme; Phillip I Bird
Journal:  J Biol Chem       Date:  2014-02-06       Impact factor: 5.157

7.  The preclinical pharmacokinetic disposition of a series of perforin-inhibitors as potential immunosuppressive agents.

Authors:  M R Bull; J A Spicer; K M Huttunen; W A Denny; A Ciccone; K A Browne; J A Trapani; N A Helsby
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-08-26       Impact factor: 2.441

8.  Modularly Constructed Synthetic Granzyme B Molecule Enables Interrogation of Intracellular Proteases for Targeted Cytotoxicity.

Authors:  Patrick Ho; Christopher Ede; Yvonne Y Chen
Journal:  ACS Synth Biol       Date:  2017-05-22       Impact factor: 5.110

9.  CD43-mediated IFN-γ production by CD8+ T cells promotes abdominal aortic aneurysm in mice.

Authors:  Hui-fang Zhou; Huimin Yan; Judy L Cannon; Luke E Springer; Jonathan M Green; Christine T N Pham
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

10.  Induction of an antitumor response using dendritic cells transfected with DNA constructs encoding the HLA-A*02:01-restricted epitopes of tumor-associated antigens in culture of mononuclear cells of breast cancer patients.

Authors:  Sergey Vital'evich Sennikov; Julia Alexandrovna Shevchenko; Vasilii Vasil'evich Kurilin; Julia Nikolaevna Khantakova; Julia Anatol'evna Lopatnikova; Elena Vasil'evna Gavrilova; Rinat Amirovich Maksyutov; Anastasiya Yur'evna Bakulina; Sergey Vasil'evich Sidorov; Alexander Alexandrovich Khristin; Amir Zakievich Maksyutov
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.